Blog

  • Lord Hylton – 2016 Parliamentary Question to the Home Office

    Lord Hylton – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Lord Hylton on 2016-03-01.

    To ask Her Majesty’s Government whether they plan to make representations to the governments of other European countries that riot police should not normally be used to control refugees and migrants in Europe.

    Lord Bates

    Our consistent focus has been on encouraging a comprehensive solution to the current migratory situation in Europe. This includes strengthening the EU’s external border and enhanced cooperation with Turkey and Western Balkans countries, as well as short and long term work with countries of transit and origin further upstream, and efforts to combat the people smugglers and traffickers who take advantage of the situation to put lives at risk.

    Public order is a matter for national governments and we expect all our international partners to ensure that migrants’ human rights are fully respected.

    We continue to work closely with our European partners to address all aspects of the current situation as it continues to develop. For those in genuine need, we are clear that protection in the region of origin is often the best solution and that those reaching the EU should claim asylum in the first Member State they enter (as per EU rules) rather than seeking to travel further across Europe to their destination of choice.

  • Lord Hylton – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Lord Hylton – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Lord Hylton on 2016-03-01.

    To ask Her Majesty’s Government whether they plan to discuss with the UNHCR the number of refugees now in detention in Thailand in unhealthy conditions and what can be done to speed up their release; and whether they plan to make representations to the government of Thailand on the detention of women and children, including pregnant women, and early release of all sick detainees.

    Baroness Anelay of St Johns

    We continue to work with the UN High Commissioner for Refugees in Thailand on a wide range of refugee issues. From our conversations with them we understand that the time taken to assess asylum applications in Thailand depends on the circumstances of each case. It can vary from a few months to a couple of years.

    We are concerned about the treatment of refugees and asylum seekers in Thailand. Although Thailand is not a signatory to the 1951 UN Convention on Refugees, we have pressed the Thai authorities to apply international humanitarian norms and standards when handling these vulnerable groups. We are also working with the Thai authorities to improve conditions of detention.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-01.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 January (HL4800), what evidence they have that suggests that the complexity of choice in wound dressings for nurses and clinicians makes their clinical decisions more difficult and can lead to over-specification and variation in standards of care.

    Lord Prior of Brampton

    The NHS Catalogue contained over 600,000 products, many of which had been not used in excess of the last 12 months or were seemingly duplicate items. Given the sheer volume of products, this creates the complexity faced by clinicians and nurses when determining the appropriate products to use, which directly makes their decisions more difficult.

    By undertaking the planned clinical rationalisation of the products available via NHS Supply Chain, the Department aims to reduce this complexity, removing unnecessary products, ensuring that those available to the National Health Service are of an appropriate specification in order to maintain high standards of patient care.

    The clinical rationalisation work is being undertaken by practising clinicians taking into account feedback from the National Institute for Health and Care Excellence and other relevant programmes, such as ‘ Getting it Right First Time’.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-01.

    To ask Her Majesty’s Government whether they plan to consider restructuring the NHS Drug Tariff Part IX on wound dressings based on their clinical performance and intended use.

    Lord Prior of Brampton

    The scope of the Department’s clinical specifications project is to assess wound care products available via the NHS Supply Chain to secondary care organisations. There are no plans at this time to extend this scope to include wound care products listed in Part IX of the Drug Tariff, which can be prescribed in primary care at National Health Service expense.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-01.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 January (HL4800), whether they are aware of any limitations regarding the data contained in the Nursing Times report in December 2014, in particular its accuracy and relevance to the UK.

    Lord Prior of Brampton

    There were 856 responses to the Royal College of Nursing survey run by Nursing Times in December 2014. The respondents were keen to get involved in the procurement process and recognised opportunities to save money.

    The respondents to the survey included a broad spectrum of nursing staff, the breakdown of which was as follows: 35% Staff nurses, 31% Clinical nurse specialists; 16% ward sisters; 10% Senior nurse managers; 4% Healthcare Assistants; 1% Directors of Nursing; and 1% Student nurses. 74% of respondents to the survey saw opportunities to reduce duplication on wound care products.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-01.

    To ask Her Majesty’s Government what action they will take to ensure that the NHS Supply Chain wound dressing generics project takes account of evidence comparing the cost of managing unhealed and healed wounds, and of the total cost of wound care in the NHS currently as compared with previous estimates.

    Lord Prior of Brampton

    The review of wound dressings by a dedicated working group resulted in the development of a number of clinical specifications for wound care products.

    In order to progress this work, from April 2016 a new NHS Clinical Evaluation Team will be put in place. The Clinical Evaluation Team will assess wound care products through a comprehensive evaluation process, which will have extensive engagement with NHS clinical staff. Included in the process will be tissue viability and infection control nurses, clinical procurement specialists, doctors, nurses and midwives along with medicine management practitioners from community trusts.

    The project’s remit is to review clinical products to identify those that enable high quality patient care whilst delivering the best outcomes for the NHS. The secondary consideration will be to identify products that could be procured more effectively through combined NHS buying power, to deliver greater overall value for money.

    The Clinical Evaluation Team is made up of practising clinicians.

    The project will therefore undertake assessments of the total costs and benefits of any recommendations to the overall NHS.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-01.

    To ask Her Majesty’s Government whether, in the light of their review of the cost of wound dressings to the NHS, they will ensure that clinical expertise is a full component part of the process in order to ensure that the outcome is clinically effective as well as cost-effective.

    Lord Prior of Brampton

    The review of wound dressings by a dedicated working group resulted in the development of a number of clinical specifications for wound care products.

    In order to progress this work, from April 2016 a new NHS Clinical Evaluation Team will be put in place. The Clinical Evaluation Team will assess wound care products through a comprehensive evaluation process, which will have extensive engagement with NHS clinical staff. Included in the process will be tissue viability and infection control nurses, clinical procurement specialists, doctors, nurses and midwives along with medicine management practitioners from community trusts.

    The project’s remit is to review clinical products to identify those that enable high quality patient care whilst delivering the best outcomes for the NHS. The secondary consideration will be to identify products that could be procured more effectively through combined NHS buying power, to deliver greater overall value for money.

    The Clinical Evaluation Team is made up of practising clinicians.

    The project will therefore undertake assessments of the total costs and benefits of any recommendations to the overall NHS.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-03-01.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 17 December 2015 (HL4371), whether they are now able to publish implementation plans for the roll-out of the system of medical examiners.

    Lord Prior of Brampton

    We remain committed to the principle of medical examiners and will be setting out further information in due course.

  • Lord Harrison – 2016 Parliamentary Question to the Department of Health

    Lord Harrison – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Harrison on 2016-03-01.

    To ask Her Majesty’s Government what is the current primary performance management mechanism through which NHS England hold Clinical Commissioning Groups to account for achieving progress in diabetes service improvement and quality of care.

    Lord Prior of Brampton

    NHS England and Monitor are working closely together to ensure that the payment system supports service developments in the vanguard sites (including those where integrated diabetes care is a focus) as well as monitoring local innovative approaches to supporting integrated care taken by some clinical commissioning groups (CCGs). This is to ensure that the payment system keeps abreast with the development of future service models and is not a barrier to the development of new models of care.

    During 2016/17, NHS England will look at the current incentives and funding arrangements for diabetes to see how greater alignment could be achieved between the financial incentives for primary and secondary care.

    Information on how much money the National Health Service invested in structured education for diabetes patients is not collected centrally.

    Under the Health and Social Care Act (2012), NHS England has a statutory duty to conduct an annual assessment of every CCG. Since April 2013, CCGs have been assessed twice, for the period 2013/14 and for 2014/15.

    For 2016/17, NHS England will introduce a new CCG Improvement and Assessment Framework (CCG IAF). This new framework will align with NHS England’s mandate and planning process, with the aim of driving improvements in a number of key areas including the management and care of people with diabetes.

    NHS England has been working with Diabetes UK on including diabetes indicators in the CCG IAF. The proposed diabetes indicators are:

    – the percentage of diabetes patients that have achieved all three of the National Institute for Heath and Care Excellence recommended treatment targets; and

    – newly diagnosed diabetes patients referred to, or attending, a structured education course.

    Under the proposals, diabetes will also be one of the six clinical priority areas in the CCG IAF that will be overseen by an independent group.

    The CCG IAF proposals are subject to the outcome of an engagement process which closed for comments on February 26 2016. More information can be found at:

    https://www.england.nhs.uk/commissioning/ccg-improvmnt/

    “

  • Lord Harrison – 2016 Parliamentary Question to the Department of Health

    Lord Harrison – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Harrison on 2016-03-01.

    To ask Her Majesty’s Government how much money the NHS invested in ensuring access to and provision of structured education for diabetes patients in (1) 2013, (2) 2014 and (3) 2015, and what percentage those figures represent of total NHS spend on diabetes during each year.

    Lord Prior of Brampton

    NHS England and Monitor are working closely together to ensure that the payment system supports service developments in the vanguard sites (including those where integrated diabetes care is a focus) as well as monitoring local innovative approaches to supporting integrated care taken by some clinical commissioning groups (CCGs). This is to ensure that the payment system keeps abreast with the development of future service models and is not a barrier to the development of new models of care.

    During 2016/17, NHS England will look at the current incentives and funding arrangements for diabetes to see how greater alignment could be achieved between the financial incentives for primary and secondary care.

    Information on how much money the National Health Service invested in structured education for diabetes patients is not collected centrally.

    Under the Health and Social Care Act (2012), NHS England has a statutory duty to conduct an annual assessment of every CCG. Since April 2013, CCGs have been assessed twice, for the period 2013/14 and for 2014/15.

    For 2016/17, NHS England will introduce a new CCG Improvement and Assessment Framework (CCG IAF). This new framework will align with NHS England’s mandate and planning process, with the aim of driving improvements in a number of key areas including the management and care of people with diabetes.

    NHS England has been working with Diabetes UK on including diabetes indicators in the CCG IAF. The proposed diabetes indicators are:

    – the percentage of diabetes patients that have achieved all three of the National Institute for Heath and Care Excellence recommended treatment targets; and

    – newly diagnosed diabetes patients referred to, or attending, a structured education course.

    Under the proposals, diabetes will also be one of the six clinical priority areas in the CCG IAF that will be overseen by an independent group.

    The CCG IAF proposals are subject to the outcome of an engagement process which closed for comments on February 26 2016. More information can be found at:

    https://www.england.nhs.uk/commissioning/ccg-improvmnt/

    “